{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T11:13:16Z","timestamp":1775041996863,"version":"3.50.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T00:00:00Z","timestamp":1772150400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"vor","delay-in-days":33,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2022R1A6A3A01087141"],"award-info":[{"award-number":["2022R1A6A3A01087141"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["RS-2023-00245919"],"award-info":[{"award-number":["RS-2023-00245919"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","award":["2120240615350"],"award-info":[{"award-number":["2120240615350"]}],"id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002461","name":"Chungbuk National University","doi-asserted-by":"publisher","award":["BK21 program (2024)"],"award-info":[{"award-number":["BK21 program (2024)"]}],"id":[{"id":"10.13039\/501100002461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2024-00342111"],"award-info":[{"award-number":["RS-2024-00342111"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["NRF-2021M3H9A2096953"],"award-info":[{"award-number":["NRF-2021M3H9A2096953"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014188","name":"Ministry of Science and ICT, South Korea","doi-asserted-by":"publisher","award":["RS-2025-19922981"],"award-info":[{"award-number":["RS-2025-19922981"]}],"id":[{"id":"10.13039\/501100014188","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003715","name":"Korea Research Institute of Bioscience and Biotechnology","doi-asserted-by":"publisher","award":["KGM5192531"],"award-info":[{"award-number":["KGM5192531"]}],"id":[{"id":"10.13039\/501100003715","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Med"],"DOI":"10.1186\/s12916-026-04745-8","type":"journal-article","created":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T02:05:19Z","timestamp":1772157919000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Transcriptome-based high-frequency recurrence index predicts frequent recurrence in non-muscle-invasive bladder cancer after Bacillus Calmette-Gu\u00e9rin therapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Seung-Woo","family":"Baek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Joon","family":"Byun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan-Mei","family":"Piao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jee-Woo","family":"Seo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Il-San","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Otabek","family":"Kamarov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seongmin","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyeong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ho Won","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Tae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung Hyun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sung-Kwon","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wun-Jae","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Young Deuk","family":"Choi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seon-Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seon-Kyu","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seok Joong","family":"Yun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,2,27]]},"reference":[{"issue":"3","key":"4745_CR1","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"4745_CR2","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/s41568-020-00313-1","volume":"21","author":"L Tran","year":"2021","unstructured":"Tran L, Xiao JF, Agarwal N, Duex JE, Theodorescu D. Advances in bladder cancer biology and therapy. Nat Rev Cancer. 2021;21(2):104\u201321.","journal-title":"Nat Rev Cancer"},{"issue":"10061","key":"4745_CR3","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1016\/S0140-6736(16)30512-8","volume":"388","author":"AM Kamat","year":"2016","unstructured":"Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmstrom PU, Choi W, et al. Bladder cancer. Lancet. 2016;388(10061):2796\u2013810.","journal-title":"Lancet"},{"issue":"1","key":"4745_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comperat EM, Dominguez Escrig JL, et al. European Association of Urology Guidelines on Non-muscle-invasive Bladder Cancer (Ta, T1, and carcinoma in situ). Eur Urol. 2022;81(1):75\u201394.","journal-title":"Eur Urol"},{"key":"4745_CR5","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.urology.2022.12.009","volume":"173","author":"V Sharma","year":"2023","unstructured":"Sharma V, Chamie K, Schoenberg M, Lee VS, Fero K, Lec P, et al. Natural history of multiple recurrences in intermediate-risk non-muscle invasive bladder cancer: lessons from a prospective cohort. Urology. 2023;173:134\u201341.","journal-title":"Urology"},{"key":"4745_CR6","doi-asserted-by":"crossref","unstructured":"Sylvester RJ, van der Meijden AP, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DW, Kurth K: Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006, 49(3):466\u2013465; discussion 475\u2013467.","DOI":"10.1016\/j.eururo.2005.12.031"},{"issue":"1","key":"4745_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22465-w","volume":"12","author":"SV Lindskrog","year":"2021","unstructured":"Lindskrog SV, Prip F, Lamy P, Taber A, Groeneveld CS, Birkenkamp-Demtroder K, et al. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat Commun. 2021;12(1):2301.","journal-title":"Nat Commun"},{"issue":"12","key":"4745_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100472","volume":"2","author":"CD Hurst","year":"2021","unstructured":"Hurst CD, Cheng G, Platt FM, Castro MAA, Marzouka NS, Eriksson P, et al. Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight. Cell Rep Med. 2021;2(12):100472.","journal-title":"Cell Rep Med"},{"key":"4745_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2022.104092","volume":"81","author":"SW Baek","year":"2022","unstructured":"Baek SW, Mun JY, Jang IH, Yang GE, Jeong MS, Kim SK, et al. YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer. EBioMedicine. 2022;81:104092.","journal-title":"EBioMedicine"},{"issue":"4","key":"4745_CR10","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1016\/j.eururo.2024.01.001","volume":"85","author":"SK Kim","year":"2024","unstructured":"Kim SK, Byun YJ, Park SH, Piao XM, Zheng CM, Moon S, et al. A 23-gene prognostic index predicts progression and Bacillus Calmette-Guerin response in non-muscle-invasive bladder cancer. Eur Urol. 2024;85(4):400\u20132.","journal-title":"Eur Urol"},{"key":"4745_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ebiom.2019.10.058","volume":"50","author":"BN Song","year":"2019","unstructured":"Song BN, Kim SK, Mun JY, Choi YD, Leem SH, Chu IS. Identification of an immunotherapy-responsive molecular subtype of bladder cancer. EBioMedicine. 2019;50:238\u201345.","journal-title":"EBioMedicine"},{"issue":"12","key":"4745_CR12","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1158\/1078-0432.CCR-06-2940","volume":"13","author":"L Dyrskjot","year":"2007","unstructured":"Dyrskjot L, Zieger K, Real FX, Malats N, Carrato A, Hurst C, et al. Gene expression signatures predict outcome in non-muscle-invasive bladder carcinoma: a multicenter validation study. Clin Cancer Res. 2007;13(12):3545\u201351.","journal-title":"Clin Cancer Res"},{"issue":"16","key":"4745_CR13","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1200\/JCO.2009.25.0977","volume":"28","author":"JS Lee","year":"2010","unstructured":"Lee JS, Leem SH, Lee SY, Kim SC, Park ES, Kim SB, et al. Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J Clin Oncol. 2010;28(16):2660\u20137.","journal-title":"J Clin Oncol"},{"key":"4745_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-9-3","volume":"9","author":"WJ Kim","year":"2010","unstructured":"Kim WJ, Kim EJ, Kim SK, Kim YJ, Ha YS, Jeong P, et al. Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. Mol Cancer. 2010;9:3.","journal-title":"Mol Cancer"},{"issue":"12","key":"4745_CR15","doi-asserted-by":"publisher","first-page":"3233","DOI":"10.1158\/1078-0432.CCR-13-2761","volume":"20","author":"SK Kim","year":"2014","unstructured":"Kim SK, Roh YG, Park K, Kang TH, Kim WJ, Lee JS, et al. Expression signature defined by FOXM1-CCNB1 activation predicts disease recurrence in non-muscle-invasive bladder cancer. Clin Cancer Res. 2014;20(12):3233\u201343.","journal-title":"Clin Cancer Res"},{"key":"4745_CR16","unstructured":"Baek SW, Byun YJ. High-frequency recurrence index for predicting multiple recurrences in non-muscle-invasive bladder cancer (discovery cohort). Gene Expression Omnibus https:\/\/identifiers.org\/geo:GSE294703 (2026)."},{"key":"4745_CR17","unstructured":"Baek SW, Byun YJ. High-frequency recurrence index for predicting multiple recurrences in non-muscle-invasive bladder cancer (validation cohort). Gene Expression Omnibus https:\/\/identifiers.org\/geo:GSE294705 (2026)."},{"issue":"1","key":"4745_CR18","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321.","journal-title":"Bioinformatics"},{"key":"4745_CR19","unstructured":"Lindskrog SV. UROMOL 2020 - RNA-seq data. European Genome-phenome Archive (EGA) https:\/\/identifiers.org\/ega.dataset:EGAD00001006656 (2020)."},{"key":"4745_CR20","unstructured":"Dyrskjot L. Gene expression signatures predict outcome in non-muscle invasive bladder carcinoma - a multi-center validation study. Gene Expression Omnibus https:\/\/identifiers.org\/geo:GSE5479 (2006)."},{"key":"4745_CR21","unstructured":"Leem S CI, Kim Y, Kim S, Kim W. Predective value of prognosis-related gene expression study in primary bladder cancer. Gene Expression Omnibus https:\/\/identifiers.org\/geo:GSE13507 (2008)."},{"key":"4745_CR22","unstructured":"Song B KS, Leem S, Chu I. Comprehensive molecular classification of bladder cancer reveals distinct prognostic subgroups with different sensitivities to immunotherapy. Gene Expression Omnibus https:\/\/identifiers.org\/geo:GSE120736 (2018)."},{"key":"4745_CR23","unstructured":"CD H, MA K. Expression analysis of human stage Ta and stage T1 bladder tumours. Gene Expression Omnibus https:\/\/identifiers.org\/geo:GSE163209 (2020)."},{"key":"4745_CR24","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"4745_CR25","doi-asserted-by":"publisher","first-page":"496","DOI":"10.20892\/j.issn.2095-3941.2016.0066","volume":"13","author":"NA Soliman","year":"2016","unstructured":"Soliman NA, Yussif SM. Ki-67 as a prognostic marker according to breast cancer molecular subtype. Cancer Biol Med. 2016;13(4):496\u2013504.","journal-title":"Cancer Biol Med"},{"key":"4745_CR26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2023.1157115","volume":"13","author":"G Zhang","year":"2023","unstructured":"Zhang G, Tai P, Fang J, Chen A, Chen X, Cao K. Molecular subtypes based on centrosome-related genes can predict prognosis and therapeutic responsiveness in patients with low-grade gliomas. Front Oncol. 2023;13:1157115.","journal-title":"Front Oncol"},{"issue":"8","key":"4745_CR27","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2023.30961","volume":"6","author":"J Lee","year":"2023","unstructured":"Lee J, Lee YJ, Bae SJ, Baek SH, Kook Y, Cha YJ, et al. Ki-67, 21-gene recurrence score, endocrine resistance, and survival in patients with breast cancer. JAMA Netw Open. 2023;6(8):e2330961.","journal-title":"JAMA Netw Open"},{"key":"4745_CR28","doi-asserted-by":"crossref","unstructured":"Sriramulu S, Thoidingjam S, Chen WM, Hassan O, Siddiqui F, Brown SL, Movsas B, Green MD, Davis AJ, Speers C et al: BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer. bioRxiv 2024.","DOI":"10.1101\/2024.05.07.592812"},{"key":"4745_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.824208","volume":"12","author":"X Zheng","year":"2022","unstructured":"Zheng X, Liu X, Lei Y, Wang G, Liu M. Glypican-3: a novel and promising target for the treatment of hepatocellular carcinoma. Front Oncol. 2022;12:824208.","journal-title":"Front Oncol"},{"issue":"1","key":"4745_CR30","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1038\/s41417-021-00303-x","volume":"29","author":"K Kohli","year":"2022","unstructured":"Kohli K, Pillarisetty VG, Kim TS. Key chemokines direct migration of immune cells in solid tumors. Cancer Gene Ther. 2022;29(1):10\u201321.","journal-title":"Cancer Gene Ther"},{"issue":"8","key":"4745_CR31","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.1172\/JCI91190","volume":"127","author":"M Ayers","year":"2017","unstructured":"Ayers M, Lunceford J, Nebozhyn M, Murphy E, Loboda A, Kaufman DR, et al. IFN-gamma-related mRNA profile predicts clinical response to PD-1 blockade. J Clin Invest. 2017;127(8):2930\u201340.","journal-title":"J Clin Invest"},{"key":"4745_CR32","unstructured":"P. Gontero (Chair) EC, J.L. Dominguez Escrig,, F. Liedberg PM, A. Masson-Lecomte, A.H. Mostafid,, B.W.G. van Rhijn MR, T. Seisen,, S.F. Shariat ENX, Patient Advocates: I. G\u00fcrses Andersson RW, Guidelines Associates: O. Capoun BP, B.P. Rai FS, V. Soukup, Bezuidenhout GOC: EAU guidelines on non-muscle-invasive bladder-cancer. In: The EAU Annual Congress. Milan; 2023."},{"issue":"18","key":"4745_CR33","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/BF03262330","volume":"21","author":"MF Botteman","year":"2003","unstructured":"Botteman MF, Pashos CL, Redaelli A, Laskin B, Hauser R. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics. 2003;21(18):1315\u201330.","journal-title":"Pharmacoeconomics"},{"issue":"7693","key":"4745_CR34","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"1","key":"4745_CR35","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06654-8","volume":"9","author":"A Chakravarthy","year":"2018","unstructured":"Chakravarthy A, Khan L, Bensler NP, Bose P, De Carvalho DD. TGF-beta-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure. Nat Commun. 2018;9(1):4692.","journal-title":"Nat Commun"},{"key":"4745_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1013506","volume":"13","author":"A Zheng","year":"2022","unstructured":"Zheng A, Wei Y, Zhao Y, Zhang T, Ma X. The role of cancer-associated mesothelial cells in the progression and therapy of ovarian cancer. Front Immunol. 2022;13:1013506.","journal-title":"Front Immunol"},{"issue":"1","key":"4745_CR37","doi-asserted-by":"publisher","first-page":"4703","DOI":"10.1038\/s41467-023-40398-4","volume":"14","author":"A Castiglioni","year":"2023","unstructured":"Castiglioni A, Yang Y, Williams K, Gogineni A, Lane RS, Wang AW, et al. Combined PD-L1\/TGFbeta blockade allows expansion and differentiation of stem cell-like CD8 T cells in immune excluded tumors. Nat Commun. 2023;14(1):4703.","journal-title":"Nat Commun"}],"container-title":["BMC Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12916-026-04745-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04745-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12916-026-04745-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T09:29:28Z","timestamp":1775035768000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12916-026-04745-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,27]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4745"],"URL":"https:\/\/doi.org\/10.1186\/s12916-026-04745-8","relation":{},"ISSN":["1741-7015"],"issn-type":[{"value":"1741-7015","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,27]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 February 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All patient-derived tissues were collected after surgery at Chungbuk National University Hospital (CBNUH) in accordance with institutional procedures. The study was approved by the Institutional Review Board of Chungbuk National University and CBNUH (IRB approval numbers: CBNU-202309-BR-0201 and GR2010-12\u2013010, respectively), and written informed consent was obtained from all participants prior to enrollment. Specimens were provided by CBNUH, a member of the National Biobank of Korea supported by the Ministry of Health, Welfare and Family Affairs, and all biobank samples were obtained under IRB-approved protocols with informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"196"}}